Document is current

Letter to the editor: Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization

Crossref DOI link: https://doi.org/10.1007/s00417-015-3170-4

Published Online: 2015-09-16

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy